RxDoctor Payments DataLook up a doctor →

Sherry Basile

Medical · Greensburg, PANPI 1265539977

Payments from drug & device makers

$17,810in general payments, 2019–2025

Across 1,039 payments — averaging $17.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$3K
  • Lilly USA, LLC$2K
  • Cequr Corporation$1K
  • Mannkind Corporation$1K
  • Dexcom, Inc.$1K
  • Boehringer Ingelheim$1K
  • plus $8K from 38 others

What the payments were for

  • Food & beverage$17,53598%
  • Education$2151%
  • Gifts$590%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,810 in reported general payments places this provider in the 95th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide1,078$1,176,474
JardianceEmpagliflozin431$388,812
TrulicityDulaglutide186$217,676
Soliqua 100-33Insulin Glargine/Lixisenatide180$201,351
FarxigaDapagliflozin Propanediol220$195,001
MounjaroTirzepatide172$182,072
Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/799$85,691
TradjentaLinagliptin131$84,019
Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog75$80,529
Humulin R U-500 KwikpenInsulin Regular, Human43$72,528
Xultophy 100-3.6Insulin Degludec/Liraglutide29$69,634
JanuviaSitagliptin Phosphate83$65,892
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog75$57,741
Tresiba Flextouch U-200Insulin Degludec51$50,626
Humalog Kwikpen U-200Insulin Lispro15$49,661

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic, Xultophy 100-3.6, Novolog, Fiasp$2,759$1,294,3411,234 claims
Boehringer IngelheimJardiance, Tradjenta, Synjardy, Jentadueto$1,137$531,840645 claims
Lilly USA, LLCTrulicity, Mounjaro, Humalog$1,950$420,664439 claims
Sanofi-aventis U.S. LLCSoliqua 100-33, Admelog$498$209,196193 claims
AstraZenecaFarxiga$628$195,001220 claims
MerckJanuvia$169$65,89283 claims
Johnson & JohnsonInvokana, Invokamet$183$34,46350 claims
AbbVieSynthroid, Armour Thyroid$241$26,349414 claims
Amneal Pharmaceuticals LLCLevothyroxine Sodium$216$12,6841,288 claims
Cequr CorporationCequr Simplicity$1,452$10,13714 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 2,594 medical providers in Pennsylvania.

Other medical in Greensburg

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →